PVR and malignant colon neoplasm: CD155 also affects the activation of AKT in colon cancer; in CT26 and Sw620 colon cancer cells, the knockdown of CD155 inhibits the expression of Cyclin D1 and CDK4, inducing the arrest of the cell cycle in G1, further suppressing the growth of tumor cells.